4.5 Article

Sex differences in kidney gene expression during the life cycle of F344 rats

期刊

BIOLOGY OF SEX DIFFERENCES
卷 4, 期 -, 页码 -

出版社

BIOMED CENTRAL LTD
DOI: 10.1186/2042-6410-4-14

关键词

-

向作者/读者索取更多资源

Background: The kidney functions in key physiological processes to filter blood and regulate blood pressure via key molecular transporters and ion channels. Sex-specific differences have been observed in renal disease incidence and progression, as well as acute kidney injury in response to certain drugs. Although advances have been made in characterizing the molecular components involved in various kidney functions, the molecular mechanisms responsible for sex differences are not well understood. We hypothesized that the basal expression levels of genes involved in various kidney functions throughout the life cycle will influence sex-specific susceptibilities to adverse renal events. Methods: Whole genome microarray gene expression analysis was performed on kidney samples collected from untreated male and female Fischer 344 (F344) rats at eight age groups between 2 and 104 weeks of age. Results: A combined filtering approach using statistical (ANOVA or pairwise t test, FDR 0.05) and fold-change criteria (>1.5 relative fold change) was used to identify 7,447 unique differentially expressed genes (DEGs). Principal component analysis (PCA) of the 7,447 DEGs revealed sex-related differences in mRNA expression at early (2 weeks), middle (8, 15, and 21 weeks), and late (104 weeks) ages in the rat life cycle. Functional analysis (Ingenuity Pathway Analysis) of these sex-different genes indicated over-representation of specific pathways and networks including renal tubule injury, drug metabolism, and immune cell and inflammatory responses. The mRNAs that code for the qualified urinary protein kidney biomarkers KIM-1, Clu, Tff3, and Lcn2 were also observed to show sex differences. Conclusions: These data represent one of the most comprehensive in-life time course studies to be published, assessing sex differences in global gene expression in the F344 rat kidney. PCA and Venn analyses reveal specific periods of sexually dimorphic gene expression which are associated with functional categories (xenobiotic metabolism and immune cell and inflammatory responses) of key relevance to acute kidney injury and chronic kidney disease, which may underlie sex-specific susceptibility. Analysis of the basal gene expression patterns of renal genes throughout the life cycle of the rat will improve the use of current and future renal biomarkers and inform our assessments of kidney injury and disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Reproductive hormone levels and differential mitochondria-related oxidative gene expression as potential mechanisms for gender differences in cardiosensitivity to Doxorubicin in tumor-bearing spontaneously hypertensive rats

Yanira Gonzalez, Kaytee L. Pokrzywinski, Elliot T. Rosen, Steven Mog, Baikuntha Aryal, Leena M. Chehab, Vikrant Vijay, Carrie L. Moland, Varsha G. Desai, Jennifer S. Dickey, V. Ashutosh Rao

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)

Article Endocrinology & Metabolism

Age and sex differences in kidney microRNA expression during the life span of F344 rats

Joshua C. Kwekel, Vikrant Vijay, Varsha G. Desai, Carrie L. Moland, James C. Fuscoe

BIOLOGY OF SEX DIFFERENCES (2015)

Article Toxicology

Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice

Laura K. Schnackenberg, Lisa Pence, Vikrant Vijay, Carrie L. Moland, Nysia George, Zhijun Cao, Li-Rong Yu, James C. Fuscoe, Richard D. Beger, Varsha G. Desai

JOURNAL OF APPLIED TOXICOLOGY (2016)

Article Pharmacology & Pharmacy

Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice

Vikrant Vijay, Carrie L. Moland, Tao Han, James C. Fuscoe, Taewon Lee, Eugene H. Herman, G. Ronald Jenkins, Sherry M. Lewis, Connie A. Cummings, Yuan Gao, Zhijun Cao, Li-Rong Yu, Varsha G. Desai

TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)

Article Pharmacology & Pharmacy

Sex-related differential susceptibility to doxorubicin-induced cardiotoxicity in B6C3F1 mice

G. Ronald Jenkins, Taewon Lee, Carrie L. Moland, Vikrant Vijay, Eugene H. Herman, Sherry M. Lewis, Kelly J. Davis, Levan Muskhelishvili, Susan Kerr, James C. Fuscoe, Varsha G. Desai

TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)

Article Multidisciplinary Sciences

Stably Expressed Genes Involved in Basic Cellular Functions

Kejian Wang, Vikrant Vijay, James C. Fuscoe

PLOS ONE (2017)

Article Endocrinology & Metabolism

Sex and age differences in the expression of liver microRNAs during the life span of F344 rats

Joshua C. Kwekel, Vikrant Vijay, Tao Han, Carrie L. Moland, Varsha G. Desai, James C. Fuscoe

BIOLOGY OF SEX DIFFERENCES (2017)

Article Multidisciplinary Sciences

In Vitro Modulation of Redox and Metabolism Interplay at the Brain Vascular Endothelium: Genomic and Proteomic Profiles of Sulforaphane Activity

Ravi K. Sajja, Mohammad A. Kaisar, Vikrant Vijay, Varsha G. Desai, Shikha Prasad, Luca Cucullo

SCIENTIFIC REPORTS (2018)

Article Reproductive Biology

Transcript profiling in the testes and prostates of postnatal day 30 Sprague-Dawley rats exposed prenatally and lactationally to 2-hydroxy-4-methoxybenzophenone

Noriko Nakamura, Vikrant Vijay, Varsha G. Desai, Deborah K. Hansen, Tao Han, Ching-Wei Chang, Yu-Chuan Chen, Wafa Harrouk, Barry McIntyre, Paul M. Foster, James C. Fuscoe, Amy L. Inselman

REPRODUCTIVE TOXICOLOGY (2018)

Article Pharmacology & Pharmacy

Candidate early predictive plasma protein markers of doxorubicin-induced chronic cardiotoxicity in B6C3F1 mice

Varsha G. Desai, Taewon Lee, Carrie L. Moland, Vikrant Vijay, Tao Han, Sherry M. Lewis, Eugene H. Herman, James C. Fuscoe

TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)

Letter Reproductive Biology

Rebuttal to the comments by Dr. Yan Xu on the article Transcript profiling in the testes and prostates of postnatal day 30 Sprague-Dawley rats exposed prenatally and lactationally to 2-hydroxy-4-methoxybenzophenone

Noriko Nakamura, Vikrant Vijay, Varsha G. Desai, Deborah K. Hansen, Tao Han, Ching-Wei Chang, Yu-Chuan Chen, Wafa Harrouk, Barry McIntyre, Paul M. Foster, James C. Fuscoe, Amy L. Inselman

REPRODUCTIVE TOXICOLOGY (2020)

Article Pharmacology & Pharmacy

Hepatic Transcript Profiles of Cytochrome P450 Genes Predict Sex Differences in Drug Metabolism

James C. Fuscoe, Vikrant Vijay, Joseph P. Hanig, Tao Han, Lijun Ren, James J. Greenhaw, Richard D. Beger, Lisa M. Pence, Qiang Shi

DRUG METABOLISM AND DISPOSITION (2020)

Article Toxicology

Doxorubicin-induced delayed-onset subclinical cardiotoxicity in mice

Varsha G. Desai, Vikrant Vijay, Tao Han, Carrie L. Moland, Bounleut Phanavanh, Taewon Lee, Kelly J. Davis, Levan Muskhelishvili, Kimo C. Stine, James C. Fuscoe

Summary: Research suggests that low doses of doxorubicin may lead to cardiotoxicity and subsequent cardiomyopathy. Experiments on mice showed that higher cumulative doses of DOX were associated with decreased cardiac function and increased cardiomyocyte apoptosis.

JOURNAL OF APPLIED TOXICOLOGY (2022)

Editorial Material Medicine, Legal

Progress towards an OECD reporting framework for transcriptomics and metabolomics in regulatory toxicology

Joshua A. Harrill, Mark R. Viant, Carole L. Yauk, Magdalini Sachana, Timothy W. Gant, Scott S. Auerbach, Richard D. Beger, Mounir Bouhifd, Jason O'Brien, Lyle Burgoon, Florian Caiment, Donatella Carpi, Tao Chen, Brian N. Chorley, John Colbourne, Raffaella Corvi, Laurent Debrauwer, Claire O'Donovan, Timothy M. D. Ebbels, Drew R. Ekman, Frank Faulhammer, Laura Gribaldo, Gina M. Hilton, Stephanie P. Jones, Aniko Kende, Thomas N. Lawson, Sofia B. Leite, Pim E. G. Leonards, Mirjam Luijten, Alberto Martin, Laura Moussa, Serge Rudaz, Oliver Schmitz, Tomasz Sobanski, Volker Strauss, Monica Vaccari, Vikrant Vijay, Ralf J. M. Weber, Antony J. Williams, Andrew Williams, Russell S. Thomas, Maurice Whelan

Summary: Omics methodologies are widely used in toxicological research, but face challenges in gaining widespread regulatory acceptance due to lack of transparency in data processing methods and standardization in reporting. To foster further regulatory use of Omics data, the OECD's EAGMST launched a project to develop guidance for reporting Omics data.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2021)

暂无数据